United States · FDA National Drug Code directory
ZIPRASIDONE MESYLATE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 51662-1564_1035b793-4301-3cb4-e063-6294a90a5b1f
- Product NDC
- 51662-1564
- Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Composition / generic term
- ZIPRASIDONE MESYLATE
- Labeler
- HF Acquisition Co LLC, DBA HealthFirst
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20210717
- Source listing expiry
- 20261231
Source-listed ingredients
- ZIPRASIDONE MESYLATE — 20 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 10 POUCH in 1 CASE (51662-1564-3) / 1 VIAL, SINGLE-DOSE in 1 POUCH (51662-1564-2) / 5 mL in 1 VIAL, SINGLE-DOSE · 51662-1564-3
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →